Bone Drug Fails to Prevent Breast Cancer Recurrence: Study
by on Sep.25, 2011, under Health and Fitness
SUNDAY, Sept. 25 (HealthDay News) — The bone drug Zometa, once
considered a promising weapon to reduce the risk of breast cancer
recurrence, should not be used routinely in treatment of the disease,
researchers say.
View full post on Yahoo! Health News
